• Professor
  • Yoshihiro NISHIYAMA, M.D., Ph.D.
• Associate Professor
  • Yuka YAMAMOTO, M.D., Ph.D.
• Lecturer
  • Naruhide KIMURA, M.D., Ph.D.
  • Makiko MUROTA, M.D., Ph.D.
• Assistant Professor
  • Takayuki SANOMURA, M.D., Ph.D.
  • Hanae OKUDA, M.D., Ph.D.
  • Takashi NORIKANE, M.D., Ph.D.
    
  • Mariko ISHIMURA, M.D.
  • Kenichi TANAKA, M.D., Ph.D.
• Clinical Assistant Professor
  • Katsuya MITAMURA, M.D., Ph.D.
  • Yasukage TAKAMI, M.D., Ph.D.
  • Kengo FUJIMOTO, M.D., Ph.D.
• Clinical Fellow
  • Ayumi NISHISHITA, M.D., Ph.D .
  • Masashi IMAJO, M.D.
  • Eri IMAJO, M.D.
    
  • Yuri Manabe, M.D.
  • Mitsumasa Murao, M.D.
    

• Diagnostic imaging.
• Interventional radiology.
• Nuclear medicine (PET, SPECT and radionuclide therapy).
• Molecular imaging.

• Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer.
  Ishimura M, et al. Nucl Med Commun. 43,304-309(2022).
• Correlation of 4'-[methyl- 11 C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma.
  Norikane T, et al. EJNMMI Res. 11, 42 (2021).
• Interim 4'-[methyl- 11 C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [ 18 F]FDG PET.
  Mitamura K, et al. EJNMMI Res. 11, 13 (2021).

E-mail:

 >> Lab Homepage